Literature DB >> 21900030

The effects of adding group-based lifestyle counselling to individual counselling on changes in plasma glucose levels in a randomized controlled trial: the Inter99 study.

C Lau1, D Vistisen, U Toft, I Tetens, C Glümer, O Pedersen, T Jørgensen, K Borch-Johnsen.   

Abstract

AIM: This study aimed to assess whether group-based lifestyle counselling offered to a high-risk population subgroup had any effect beyond individual multifactorial interventions on fasting plasma glucose (FPG) and 2-h plasma glucose (2hPG) changes.
METHODS: In a population-based study of 6784 participants, 4053 were determined to be at high risk based on a risk estimate of ischaemic heart disease or the presence of risk factors (smoking, hypertension, hypercholesterolaemia, obesity, impaired glucose tolerance). Of these subjects, 90% were randomized to high-intensity intervention (group A) and 10% to low-intensity intervention (group B). All participants went through health examinations, risk assessments and individual lifestyle counselling. Participants in group A were further offered group-based lifestyle counselling. The intervention was repeated after 1 and 3 years. A total of 2738 participants free of diabetes at baseline (1999-2001) and with at least one FPG and/or 2hPG measurement during 5 years of follow-up were included in the analyses. Differences in changes of plasma glucose between groups A and B were analyzed using multilevel linear regression.
RESULTS: For FPG, crude 5-year changes were significantly different between the two groups (group A: -0.003 mmol/L vs group B: -0.079 mmol/L; P=0.0427). After adjusting for relevant confounders, no differences in FPG changes were observed (P=0.116). Also, no significant differences in the 5-year changes in 2hPG between the two groups were observed (group A: - 0.127 mmol/L vs group B: -0.201 mmol/L; P=0.546).
CONCLUSION: Offering additional group-based intervention to a high-risk population subgroup had no clinical effects on changes in plasma glucose beyond those of individualized multifactorial interventions.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900030     DOI: 10.1016/j.diabet.2011.06.001

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  7 in total

1.  Increasing insulin resistance accentuates the effect of triglyceride-associated loci on serum triglycerides during 5 years.

Authors:  Johanne M Justesen; Ehm A Andersson; Kristine H Allin; Camilla H Sandholt; Torben Jørgensen; Allan Linneberg; Marit E Jørgensen; Torben Hansen; Oluf Pedersen; Niels Grarup
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

Review 2.  Exercise and diabetes-related cardiovascular disease: systematic review of published evidence from observational studies and clinical trials.

Authors:  Robert W Koivula; Asa B Tornberg; Paul W Franks
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

3.  Genetic risk score of 46 type 2 diabetes risk variants associates with changes in plasma glucose and estimates of pancreatic β-cell function over 5 years of follow-up.

Authors:  Ehm A Andersson; Kristine H Allin; Camilla H Sandholt; Anders Borglykke; Cathrine J Lau; Rasmus Ribel-Madsen; Thomas Sparsø; Johanne M Justesen; Marie N Harder; Marit E Jørgensen; Torben Jørgensen; Torben Hansen; Oluf Pedersen
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461

4.  Effectiveness of Multifaceted Care Approach on Adverse Clinical Outcomes in Nondiabetic CKD: A Systematic Review and Meta-analysis.

Authors:  Aminu K Bello; Bilal Qarni; Arian Samimi; Julius Okel; Trish Chatterley; Ikechi G Okpechi; Ben Vandermeer; Branko Braam
Journal:  Kidney Int Rep       Date:  2017-02-16

5.  Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiography.

Authors:  Maria Lukács Krogager; Regitze Kuhr Skals; Emil Vincent R Appel; Theresia M Schnurr; Line Engelbrechtsen; Christian Theil Have; Oluf Pedersen; Thomas Engstrøm; Dan M Roden; Gunnar Gislason; Henrik Enghusen Poulsen; Lars Køber; Steen Stender; Torben Hansen; Niels Grarup; Charlotte Andersson; Christian Torp-Pedersen; Peter E Weeke
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

6.  Increased frequency of rare missense PPP1R3B variants among Danish patients with type 2 diabetes.

Authors:  Robina Khan Niazi; Jihua Sun; Christian Theil Have; Mette Hollensted; Allan Linneberg; Oluf Pedersen; Jens Steen Nielsen; Jørgen Rungby; Niels Grarup; Torben Hansen; Anette Prior Gjesing
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

7.  Sequencing reveals protective and pathogenic effects on development of diabetes of rare GLIS3 variants.

Authors:  Jihua Sun; Christian Theil Have; Mette Hollensted; Niels Grarup; Allan Linneberg; Oluf Pedersen; Jens Steen Nielsen; Jørgen Rungby; Cramer Christensen; Ivan Brandslund; Karsten Kristiansen; Wang Jun; Torben Hansen; Anette P Gjesing
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.